These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8909308)

  • 1. Postoperative immunostimulation after complete resection improves survival of patients with stage I nonsmall cell lung carcinoma.
    Fujisawa T; Yamaguchi Y
    Cancer; 1996 Nov; 78(9):1892-8. PubMed ID: 8909308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized controlled study of adjuvant immunotherapy with Nocardia rubra cell wall skeleton for inoperable lung cancer.
    Yamamura Y; Ogura T; Sakatani M; Hirao F; Kishimoto S; Fukuoka M; Takada M; Kawahara M; Furuse K; Kuwahara O
    Cancer Res; 1983 Nov; 43(11):5575-9. PubMed ID: 6616485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomly controlled study of chemotherapy versus chemoimmunotherapy in postoperative lung cancer patients.
    Yasumoto K; Yaita H; Ohta M; Azuma I; Nomoto K; Inokuchi K; Yamamura Y
    Cancer Res; 1985 Mar; 45(3):1413-7. PubMed ID: 3155992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of adjuvant immunotherapy with Nocardia rubra cell-wall skeleton in lung cancer].
    Yasumoto K; Ichinose Y; Yaita H; Tanaka K; Hara N; Ohta M; Hirota N; Nomoto K; Inokuchi K; Yamamura Y
    Nihon Geka Gakkai Zasshi; 1983 Apr; 84(4):321-7. PubMed ID: 6325864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunotherapy of resectable lung cancer using Nocardia rubra cell wall skeleton].
    Ogura T
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):366-72. PubMed ID: 6349535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transfer factor immunochemotherapy for primary lung cancer--evaluation of histologic types].
    Fujisawa T; Yamaguchi Y
    Gan No Rinsho; 1983 Oct; 29(12):1409-16. PubMed ID: 6315989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous tumor killing activity as a prognostic factor in primary resected nonsmall cell carcinoma of the lung.
    Fujisawa T; Yamaguchi Y
    Cancer; 1997 Feb; 79(3):474-81. PubMed ID: 9028357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized clinical trial of non-specific immunotherapy with cell-wall skeleton of Nocardia rubra.
    Yasumoto K; Yamamura Y
    Biomed Pharmacother; 1984; 38(1):48-54. PubMed ID: 6380607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long-term survival.
    Fujimoto T; Cassivi SD; Yang P; Barnes SA; Nichols FC; Deschamps C; Allen MS; Pairolero PC
    J Thorac Cardiovasc Surg; 2006 Sep; 132(3):499-506. PubMed ID: 16935101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative adjuvant chemotherapy for stage I non-small cell lung cancer.
    Park JH; Lee CT; Lee HW; Baek HJ; Zo JI; Shim YM
    Eur J Cardiothorac Surg; 2005 Jun; 27(6):1086-91. PubMed ID: 15896623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stage IB nonsmall cell lung cancers: are they all the same?
    Jones DR; Daniel TM; Denlinger CE; Rundall BK; Smolkin ME; Wick MR
    Ann Thorac Surg; 2006 Jun; 81(6):1958-62; discussion 1962. PubMed ID: 16731113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and prognosis of patients after resection of nonsmall cell lung carcinoma measuring 2 cm or less in greatest dimension.
    Okada M; Sakamoto T; Nishio W; Uchino K; Tsubota N
    Cancer; 2003 Aug; 98(3):535-41. PubMed ID: 12879471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase III randomized study of interleukin-2 lymphokine-activated killer cell immunotherapy combined with chemotherapy or radiotherapy after curative or noncurative resection of primary lung carcinoma.
    Kimura H; Yamaguchi Y
    Cancer; 1997 Jul; 80(1):42-9. PubMed ID: 9210707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A randomized controlled study of adjuvant immunotherapy with N-CWS for head and neck malignancies].
    Sakai S; Itoh M; Matsunaga T; Yoshida J; Sato T; Miyahara Y; Matsunaga T; Hyoh Y; Ohyama K; Katsuta K
    Gan No Rinsho; 1985 Sep; 31(11):1353-61. PubMed ID: 4068237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer.
    Imaizumi M;
    Lung Cancer; 2005 Jul; 49(1):85-94. PubMed ID: 15949594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of postoperative immunotherapy of gastric cancer].
    Ochiai T; Sato H
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):373-9. PubMed ID: 6349536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival.
    Hung JJ; Wang CY; Huang MH; Huang BS; Hsu WH; Wu YC
    J Thorac Cardiovasc Surg; 2007 Sep; 134(3):638-43. PubMed ID: 17723811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of patients with non-small cell lung cancer with isolated brain metastases undergoing combined surgical treatment.
    Getman V; Devyatko E; Dunkler D; Eckersberger F; End A; Klepetko W; Marta G; Mueller MR
    Eur J Cardiothorac Surg; 2004 Jun; 25(6):1107-13. PubMed ID: 15145017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The present status of surgery for lung cancer.
    Lacquet LK
    Acta Chir Belg; 1996; 96(6):245-51. PubMed ID: 9008764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological determinants of survival in completely resected T1-2N1M0 nonsmall cell cancer of the lung.
    Khan OA; Fitzgerald JJ; Field ML; Soomro I; Beggs FD; Morgan WE; Duffy JP
    Ann Thorac Surg; 2004 Apr; 77(4):1173-8. PubMed ID: 15063229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.